Canopy Rivers Inc Share Price Toronto S.E.
Equities
CA1380411084
Pharmaceuticals
Sales 2022 | 1.9M 1.39M 110M | Sales 2023 | 7.4M 5.41M 431M | Capitalization | 10.76M 7.87M 627M |
---|---|---|---|---|---|
Net income 2022 | -52M -38.03M -3.03B | Net income 2023 | -85M -62.16M -4.95B | EV / Sales 2022 | -144 x |
Net cash position 2022 | 298M 218M 17.34B | Net Debt 2023 | 42.14M 30.81M 2.45B | EV / Sales 2023 | 7.15 x |
P/E ratio 2022 |
-0.42
x | P/E ratio 2023 |
-0.13
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 84.53% |
Latest transcript on Canopy Rivers Inc
Managers | Title | Age | Since |
---|---|---|---|
Mike Totzke
CEO | Chief Executive Officer | - | 19/06/22 |
Eddie Lucarelli
DFI | Director of Finance/CFO | - | 28/02/18 |
Amanda Rico
HRO | Human Resources Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 39 | 29/09/21 | |
Richard Mavrinac
BRD | Director/Board Member | 71 | 16/09/18 |
Chairman | - | 16/09/18 |
1st Jan change | Capi. | |
---|---|---|
+40.09% | 6.16B | |
-16.34% | 4.46B | |
-7.11% | 3.27B | |
+5.14% | 3.2B | |
-0.18% | 2.6B | |
+47.93% | 1.98B | |
-7.15% | 1.7B | |
+0.67% | 1.66B | |
-8.73% | 1.61B |